We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXT icon
2601
Rackspace Technology
RXT
$1.1B
$254K ﹤0.01%
22,736
+1,243
+6% +$14.7K
SIBN icon
2602
SI-BONE Inc
SIBN
$849M
$254K ﹤0.01%
11,237
-715
-6% -$14.8K
SPNT icon
2603
SiriusPoint
SPNT
$2.7B
$254K ﹤0.01%
34,002
-7,355
-18% -$58.2K
LPCN icon
2604
Lipocine
LPCN
$17M
$253K ﹤0.01%
10,862
VREX icon
2605
Varex Imaging
VREX
$780M
$253K ﹤0.01%
11,875
-11,139
-48% -$283K
GEVO icon
2606
Gevo
GEVO
$401M
$252K ﹤0.01%
53,930
+14,755
+38% +$56.4K
NGS icon
2607
Natural Gas Services Group
NGS
$474M
$252K ﹤0.01%
21,188
BBSI icon
2608
Barrett Business Services
BBSI
$800M
$251K ﹤0.01%
12,944
+508
+4% +$8.59K
MRTN icon
2609
Marten Transport
MRTN
$1.24B
$251K ﹤0.01%
14,110
+1,303
+10% +$22.8K
UWMC icon
2610
UWM Holdings
UWMC
$2.61B
$251K ﹤0.01%
55,397
+1,846
+3% +$8.91K
FOSL icon
2611
Fossil Group
FOSL
$330M
$250K ﹤0.01%
25,891
+5,677
+28% +$64.4K
IDT icon
2612
IDT Corp
IDT
$1.67B
$250K ﹤0.01%
7,320
-989
-12% -$36.8K
GOEV
2613
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$250K ﹤0.01%
99
+6
+6% +$16.5K
SHBI icon
2614
Shore Bancshares
SHBI
$799M
$249K ﹤0.01%
+12,150
New +$249K
SHCR
2615
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$249K ﹤0.01%
101,000
+67,800
+204% +$223K
FRPH icon
2616
FRP Holdings
FRPH
$425M
$248K ﹤0.01%
8,598
+250
+3% +$7.11K
RIGL icon
2617
Rigel Pharmaceuticals
RIGL
$762M
$248K ﹤0.01%
8,310
+2,864
+53% +$77.5K
ARC
2618
DELISTED
ARC Document Solutions, Inc.
ARC
$248K ﹤0.01%
63,502
INBK icon
2619
First Internet Bancorp
INBK
$256M
$247K ﹤0.01%
5,750
+1,223
+27% +$59.2K
LOVE
2620
LoveSac
LOVE
$258M
$246K ﹤0.01%
4,554
+286
+7% +$13.7K
BALY icon
2621
Bally's
BALY
$660M
$245K ﹤0.01%
7,973
+663
+9% +$22.4K
KROS icon
2622
Keros Therapeutics
KROS
$211M
$245K ﹤0.01%
4,505
-2,062
-31% -$106K
QMCO icon
2623
Quantum Corp
QMCO
$973M
$244K ﹤0.01%
5,364
+2,635
+97% +$193K
RSI icon
2624
Rush Street Interactive
RSI
$2.85B
$244K ﹤0.01%
33,576
+16,747
+100% +$169K
TLS icon
2625
Telos
TLS
$344M
$244K ﹤0.01%
24,470
+946
+4% +$10.6K

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.